After training in internal medicine, pediatrics, and epidemiology at the University of Tennessee and completing a hematology/oncology fellowship at St. Jude Children’s Research Hospital, Dr. Howard worked there for 16 years treating children with leukemia and lymphoma and conducting research in oncology supportive care and international oncology. He is particularly interested in management of patients with leukemia and lymphoma and all aspects of oncology supportive care (e.g. infectious complications, tumor lysis syndrome, thrombosis, venous access complications, endocrine and bone toxicities), and has experience facilitating local, national, and regional clinical research in a number of middle-income countries.
In 2015 he founded Resonance Oncology to improve care for cancer patients everywhere, but especially in low- and middle-income countries (LMIC), through research, healthcare information technology, education, and development of regional and global networks for care and research. To complement these efforts, Scott conducts translational research at the University of Memphis (Memphis, Tennessee, USA) using large animal models of chemotherapy toxicity.
Dr. Howard has a long history of working with SIOP colleagues to address issues in LMIC and to foster education and network building. He currently chairs the Clinical Practice Guidelines Committee of the American Society of Pediatric Hematology Oncology and the SIOP PODC Twinning Working Group, whose goal is to promote local, regional, and global collaboration.